Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Kristoffer Hellstrand
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Anatomy
Chemicals & Drugs
Physiology
Procedures
Living Beings
Disorders
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
41
Hermodsson, Svante
17
Naredi, Peter
16
Asea, Alexzander
13
Brune, Mats
12
Dahlgren, Claes
12
Mellqvist, Ulf-Henrik
11
Romero, Ana
9
Thorén, Fredrik
9
Westin, Johan
9
Lagging, Martin
8
Gehlsen, Kurt
8
Norkrans, Gunnar
6
Zeuzem, Stefan
6
Hoffmann, P
6
Dhillon, Amar
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Kristoffer Hellstrand (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Romero A I; Thorén F B; Aurelius J; Askarieh G; Brune M; Hellstrand K
Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML.
Scandinavian journal of immunology 2009;70(3):194-205.
-
2009: Thorén Fredrik B; Romero Ana I; Brune Mats; Hellstrand Kristoffer
Histamine dihydrochloride and low-dose interleukin-2 as post-consolidation immunotherapy in acute myeloid leukemia.
Expert opinion on biological therapy 2009;9(9):1217-23.
-
2009: Mossberg Natalia; Movitz Charlotta; Hellstrand Kristoffer; Bergström Tomas; Nilsson Staffan; Andersen Oluf
Oxygen radical production in leukocytes and disease severity in multiple sclerosis.
Journal of neuroimmunology 2009;213(1-2):131-4.
-
2009: Brune M; Romero A I; Hellstrand K
Histamine dihydrochloride and interleukin-2 in acute myeloid leukemia--background and results.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2009;58 Suppl 1():4-8.
-
2008: Lagging Martin; Langeland Nina; Pedersen Court; Färkkilä Martti; Buhl Mads Rauning; Mørch Kristine; Dhillon Amar P; Alsiö Asa; Hellstrand Kristoffer; Westin Johan; Christensen Peer; Leutscher Peter; Norkrans Gunnar;
Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2008;48(2):695.
-
2008: Lagging Martin; Langeland Nina; Pedersen Court; Färkkilä Martti; Buhl Mads Rauning; Mørch Kristine; Dhillon Amar P; Alsiö Asa; Hellstrand Kristoffer; Westin Johan; Norkrans Gunnar;
Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3 infection.
Hepatology (Baltimore, Md.) 2008;47(6):1837-45.
-
2008: Dahlberg Maria; Dahlgren Claes; Hellstrand Kristoffer; Movitz Charlotta
A new chemiluminescence paradox: selective inhibition of isoluminol-amplified activity in phagocytes by peptides from annexin AI.
Luminescence : the journal of biological and chemical luminescence 2008;23(3):139-43.
-
2008: Lindh M; Hellstrand K; Norkrans G
Wider indications for treatment of chronic hepatitis B?
Journal of viral hepatitis 2008;15(3):237.
-
2008: Westin Johan; Ydreborg Magdalena; Islam Sara; Alsiö Asa; Dhillon Amar P; Pawlotsky Jean-Michel; Zeuzem Stefan; Schalm Solko W; Ferrari Carlo; Neumann Avidan U; Hellstrand Kristoffer; Lagging Martin;
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infection.
Scandinavian journal of gastroenterology 2008;43(1):73-80.
-
2007: Mossberg Natalia; Andersen Oluf; Nilsson Staffan; Dahlgren Claes; Hellstrand Kristoffer; Lindh Magnus; Svedhem Ake; Bergström Tomas; Movitz Charlotta
Oxygen radical production and severity of the Guillain--Barré syndrome.
Journal of neuroimmunology 2007;192(1-2):186-91.
-
2007: Middleton M; Hauschild A; Thomson D; Anderson R; Burdette-Radoux S; Gehlsen K; Hellstrand K; Naredi P
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-{alpha}2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(10):1691-7.
-
2007: Lindh Magnus; Alestig Erik; Arnholm Birgitta; Eilard Anders; Hellstrand Kristoffer; Lagging Martin; Wahlberg Thomas; Wejstål Rune; Westin Johan; Norkrans Gunnar
Response prediction and treatment tailoring for chronic hepatitis C virus genotype 1 infection.
Journal of clinical microbiology 2007;45(8):2439-45.
-
2007: Thorén Fredrik B; Romero Ana I; Hermodsson Svante; Hellstrand Kristoffer
The CD16-/CD56bright subset of NK cells is resistant to oxidant-induced cell death.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(2):781-5.
-
2007: Thorén Fredrik B; Betten Asa; Romero Ana I; Hellstrand Kristoffer
Cutting edge: Antioxidative properties of myeloid dendritic cells: protection of T cells and NK cells from oxygen radical-induced inactivation and apoptosis.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(1):21-5.
-
2007: Westin Johan; Hellstrand Kristoffer; Alsiö Asa; Ydreborg Magdalena; Ferrari Carlo; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Zeuzem Stefan; Verhey-Hart Elke; Lagging Martin
Impact of disease severity on outcome of antiviral therapy in treatment-naïve patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2007;45(5):1333-4; author reply 1334.
-
2007: Westin J; Lagging M; Dhillon A P; Norkrans G; Romero A I; Pawlotsky J-M; Zeuzem S; Schalm S W; Verheij-Hart E; Negro F; Missale G; Neumann A U; Hellstrand K;
Impact of hepatic steatosis on viral kinetics and treatment outcome during antiviral treatment of chronic HCV infection.
Journal of viral hepatitis 2007;14(1):29-35.
-
2007: Lukasiewicz Esther; Hellstrand Kristoffer; Westin Johan; Ferrari Carlo; Neumann Avidan U; Pawlotsky Jean-Michel; Schalm Solko W; Zeuzem Stefan; Veldt Bart J; Hansen Bettina E; Verhey-Hart Elke; Lagging Martin
Predicting treatment outcome following 24 weeks peginterferon alpha-2a/ribavirin therapy in patients infected with HCV genotype 1: utility of HCV-RNA at day 0, day 22, day 29, and week 6.
Hepatology (Baltimore, Md.) 2007;45(1):258-9.
-
2006: Lagging Martin; Romero Ana I; Westin Johan; Norkrans Gunnar; Dhillon Amar P; Pawlotsky Jean-Michel; Zeuzem Stefan; von Wagner Michael; Negro Francesco; Schalm Solko W; Haagmans Bart L; Ferrari Carlo; Missale Gabriele; Neumann Avidan U; Verheij-Hart Elke; Hellstrand Kristoffer;
IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection.
Hepatology (Baltimore, Md.) 2006;44(6):1617-25.
-
2006: Romero Ana I; Lagging Martin; Westin Johan; Dhillon Amar P; Dustin Lynn B; Pawlotsky Jean-Michel; Neumann Avidan U; Ferrari Carlo; Missale Gabriele; Haagmans Bart L; Schalm Solko W; Zeuzem Stefan; Negro Francesco; Verheij-Hart Elke; Hellstrand Kristoffer;
Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection.
The Journal of infectious diseases 2006;194(7):895-903.
-
2006: Brune Mats; Castaigne Sylvie; Catalano John; Gehlsen Kurt; Ho Anthony D; Hofmann Wolf-Karsten; Hogge Donna E; Nilsson Bo; Or Reuven; Romero Ana I; Rowe Jacob M; Simonsson Bengt; Spearing Ruth; Stadtmauer Edward A; Szer Jeff; Wallhult Elisabeth; Hellstrand Kristoffer
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial.
Blood 2006;108(1):88-96.
-
2006: Thorén Fredrik B; Romero Ana I; Hellstrand Kristoffer
Oxygen radicals induce poly(ADP-ribose) polymerase-dependent cell death in cytotoxic lymphocytes.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(12):7301-7.
-
2006: Romero Ana I; Thorén Fredrik B; Brune Mats; Hellstrand Kristoffer
NKp46 and NKG2D receptor expression in NK cells with CD56dim and CD56bright phenotype: regulation by histamine and reactive oxygen species.
British journal of haematology 2006;132(1):91-8.
-
2005: Karlsson Jennie; Fu Huamei; Boulay François; Dahlgren Claes; Hellstrand Kristoffer; Movitz Charlotta
Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors.
Journal of leukocyte biology 2005;78(3):762-71.
-
2005: Asemissen Anne Marie; Scheibenbogen Carmen; Letsch Anne; Hellstrand Kristoffer; Thorén Fredrik; Gehlsen Kurt; Schmittel Alexander; Thiel Eckhard; Keilholz Ulrich
Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):290-7.
-
2004: Thorén Fredrik; Romero Ana; Lindh Magnus; Dahlgren Claes; Hellstrand Kristoffer
A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals.
Journal of leukocyte biology 2004;76(6):1180-6.
-
2004: Hansson Markus; Romero Ana; Thorén Fredrik; Hermodsson Svante; Hellstrand Kristoffer
Activation of cytotoxic lymphocytes by interferon-alpha: role of oxygen radical-producing mononuclear phagocytes.
Journal of leukocyte biology 2004;76(6):1207-13.
-
2004: Agarwala Sanjiv S; Hellstrand Kristoffer; Gehlsen Kurt; Naredi Peter
Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis.
Cancer immunology, immunotherapy : CII 2004;53(9):840-1.
-
2004: Betten Asa; Dahlgren Claes; Mellqvist Ulf-Henrik; Hermodsson Svante; Hellstrand Kristoffer
Oxygen radical-induced natural killer cell dysfunction: role of myeloperoxidase and regulation by serotonin.
Journal of leukocyte biology 2004;75(6):1111-5.
-
2004: Lindnér Per; Rizell Magnus; Mattsson Jan; Hellstrand Kristoffer; Naredi Peter
Combined treatment with histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma.
Anticancer research 2004;24(3b):1837-42.
-
2004: Bylund Johan; Pellmé Sara; Fu Huamei; Mellqvist Ulf-Henrik; Hellstrand Kristoffer; Karlsson Anna; Dahlgren Claes
Cytochalasin B triggers a novel pertussis toxin sensitive pathway in TNF-alpha primed neutrophils.
BMC cell biology 2004;5():21.
-
2003: Betten A; Dahlgren C; Hermodsson S; Hellstrand K
Histamine inhibits neutrophil NADPH oxidase activity triggered by the lipoxin A4 receptor-specific peptide agonist Trp-Lys-Tyr-Met-Val-Met.
Scandinavian journal of immunology 2003;58(3):321-6.
-
2003: Hellstrand Kristoffer
Melanoma immunotherapy: a battle against radicals?
Trends in immunology 2003;24(5):232-3; author reply 234.
-
2003: Jørkov Andreas Schjellerup; Donskov Frede; Steiniche Torben; Ternesten-Bratel Annika; Naredi Peter; Hellstrand Kristoffer; Hokland Marianne
Immune response in blood and tumour tissue in patients with metastatic malignant melanoma treated with IL-2, IFN alpha and histamine dihydrochloride.
Anticancer research 2003;23(1B):537-42.
-
2002: Bokarewa Maria I; Hellstrand Kristoffer; Tarkowski Andrej
Phosphorotioated oligonucleotides trigger synthesis of human coagulation serine proteases.
Thrombosis and haemostasis 2002;88(5):788-93.
-
2002: Lurie Y; Nevens F; Aprosina Z G; Fedorova T A; Kalinin A V; Klimova E A; Ilan Y; Maevskaya M V; Warnes T W; Yuschuk N D; Hellstrand K; Gehlsen K R
A multicentre, randomized study to evaluate the safety and efficacy of histamine dihydrochloride and interferon-alpha-2b for the treatment of chronic hepatitis C.
Journal of viral hepatitis 2002;9(5):346-53.
-
2002: Agarwala Sanjiv S; Hellstrand Kristoffer; Naredi Peter
Interleukin-2 and histamine dihydrochloride in metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(16):3558-9.
-
2002: Rizell Magnus; Hellstrand Kristoffer; Lindnér Per; Naredi Peter
Monotherapy with histamine dihydrochloride suppresses in vivo growth of a rat sarcoma in liver and subcutis.
Anticancer research 2002;22(4):1943-8.
-
2002: Hellstrand Kristoffer
Histamine in cancer immunotherapy: a preclinical background.
Seminars in oncology 2002;29(3 Suppl 7):35-40.
-
2002: Donskov F; von der Maase H; Henriksson R; Stiemer U; Wersäll P; Nellemann H; Hellstrand K; Engman K; Naredi P
Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(3):441-9.
-
2002: Rizell Magnus; Naredi Peter; Lindnér Per; Hellstrand Kristoffer; Sarno Mark; Jansson Per-Anders
Histamine pharmacokinetics in tumor and host tissues after bolus-dose administration in the rat.
Life sciences 2002;70(8):969-76.
-
2002: Agarwala Sanjiv S; Glaspy John; O'Day Steven J; Mitchell Malcolm; Gutheil John; Whitman Eric; Gonzalez Rene; Hersh Evan; Feun Lynn; Belt Robert; Meyskens Frank; Hellstrand Kristoffer; Wood Diana; Kirkwood John M; Gehlsen Kurt R; Naredi Peter
Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):125-33.
-
2001: Betten A; Bylund J; Christophe T; Boulay F; Romero A; Hellstrand K; Dahlgren C
A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis.
The Journal of clinical investigation 2001;108(8):1221-8.
-
2001: Betten A; Dahlgren C; Hermodsson S; Hellstrand K
Serotonin protects NK cells against oxidatively induced functional inhibition and apoptosis.
Journal of leukocyte biology 2001;70(1):65-72.
-
2000: Hellstrand K; Brune M; Dahlgren C; Hansson M; Hermodsson S; Lindnér P; Mellqvist U H; Naredi P
Alleviating oxidative stress in cancer immunotherapy: a role for histamine?
Medical oncology (Northwood, London, England) 2000;17(4):258-69.
-
2000: Mellqvist U H; Hansson M; Brune M; Dahlgren C; Hermodsson S; Hellstrand K
Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: role of reactive oxygen species and regulation by histamine.
Blood 2000;96(5):1961-8.
-
2000: Hellstrand K; Hansson M; Hermodsson S
Adjuvant histamine in cancer immunotherapy.
Seminars in cancer biology 2000;10(1):29-39.
-
2000: Jonsdottir I H; Hellstrand K; Thorén P; Hoffmann P
Enhancement of natural immunity seen after voluntary exercise in rats. Role of central opioid receptors.
Life sciences 2000;66(13):1231-9.
-
2000: Hellstrand K; Brune M; Naredi P; Mellqvist U H; Hansson M; Gehlsen K R; Hermodsson S
Histamine: a novel approach to cancer immunotherapy.
Cancer investigation 2000;18(4):347-55.
-
1999: Hansson M; Hermodsson S; Brune M; Mellqvist U H; Naredi P; Betten A; Gehlsen K R; Hellstrand K
Histamine protects T cells and natural killer cells against oxidative stress.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(10):1135-44.
-
1999: Rizell M; Naredi P; Lindnér P; Hellstrand K; Jansson P A
Validation of the internal reference technique for microdialysis measurements of interstitial histamine in the rat.
Life sciences 1999;65(17):1765-71.
-
1998: Hellstrand K; Brune M; Mellqvist U H; Norkrans G; Lundberg P A; Hermodsson S; Wejstål R
Histamine and the response to IFN-alpha in chronic hepatitis C.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(1):21-2.
-
1998: Hellstrand K; Hermodsson S; Naredi P; Mellqvist U H; Brune M
Histamine and cytokine therapy.
Acta oncologica (Stockholm, Sweden) 1998;37(4):347-53.
-
1997: Hellstrand K; Mellqvist U H; Wallhult E; Carneskog J; Kimby E; Celsing F; Brune M
Histamine and interleukin-2 in acute myelogenous leukemia.
Leukemia & lymphoma 1997;27(5-6):429-38.
-
1997: Cvetkovska E; Asea A; Hellstrand K; Edström S
Tumor suppressive action of indomethacin is NK-cell-independent.
Anticancer research 1997;17(5A):3403-7.
-
1997: Jonsdottir I H; Johansson C; Asea A; Johansson P; Hellstrand K; Thorén P; Hoffmann P
Duration and mechanisms of the increased natural cytotoxicity seen after chronic voluntary exercise in rats.
Acta physiologica Scandinavica 1997;160(4):333-9.
-
1997: Hellstrand K; Hermodsson S; Brune M; Naredi P; Carneskog J; Mellqvist U H
Histamine in cancer immunotherapy.
Scandinavian journal of clinical and laboratory investigation 1997;57(3):193-202.
-
1996: Brune M; Hansson M; Mellqvist U H; Hermodsson S; Hellstrand K
NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites.
European journal of haematology 1996;57(4):312-9.
-
1996: Jonsdottir I H; Johansson C; Asea A; Hellstrand K; Hoffmann P
Acute mental stress but not enforced muscle activity transiently increases natural cytotoxicity in spontaneously hypertensive rats.
Acta physiologica Scandinavica 1996;157(4):443-9.
-
1996: Hansson M; Asea A; Hermodsson S; Hellstrand K
Histaminergic regulation of NK-cells: protection against monocyte-induced apoptosis.
Scandinavian journal of immunology 1996;44(2):193-6.
-
1996: Asea A; Hansson M; Czerkinsky C; Houze T; Hermodsson S; Strannegård O; Hellstrand K
Histaminergic regulation of interferon-gamma (IFN-gamma) production by human natural killer (NK) cells.
Clinical and experimental immunology 1996;105(2):376-82.
-
1996: Jonsdottir I H; Asea A; Hoffmann P; Dahlgren U I; Andersson B; Hellstrand K; Thorén P
Voluntary chronic exercise augments in vivo natural immunity in rats.
Journal of applied physiology (Bethesda, Md. : 1985) 1996;80(5):1799-803.
-
1996: Jonsdottir I H; Johansson C; Asea A; Hellstrand K; Thorén P; Hoffmann P
Chronic intracerebroventricular administration of beta-endorphin augments natural killer cell cytotoxicity in rats.
Regulatory peptides 1996;62(2-3):113-8.
-
1996: Hellstrand K; Brune M; Mellqvist U H; Naredi P
Histamine, cimetidine and colorectal cancer.
Nature medicine 1996;2(4):364-5.
-
1996: Hansson M; Asea A; Ersson U; Hermodsson S; Hellstrand K
Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(1):42-7.
-
1996: Asea A; Hermodsson S; Hellstrand K
Histaminergic regulation of natural killer cell-mediated clearance of tumour cells in mice.
Scandinavian journal of immunology 1996;43(1):9-15.
-
1996: Jonsdottir I H; Asea A; Hoffmann P; Hellstrand K; Thorén P
Natural immunity and chronic exercise in rats. The involvement of the spleen and the splenic nerves.
Life sciences 1996;58(23):2137-46.
-
1995: Hellstrand K; Asea A; Hermodsson S
Role of histamine in natural killer cell-dependent protection against herpes simplex virus type 2 infection in mice.
Clinical and diagnostic laboratory immunology 1995;2(3):277-80.
-
1995: Wängberg B; Ahlman H; Tylén U; Nilsson O; Hermodsson S; Hellstrand K
Accumulation of natural killer cells after hepatic artery embolisation in the midgut carcinoid syndrome.
British journal of cancer 1995;71(3):617-8.
-
1994: Hellstrand K; Naredi P; Lindner P; Lundholm K; Rudenstam C M; Hermodsson S; Asztély M; Hafström L
Histamine in immunotherapy of advanced melanoma: a pilot study.
Cancer immunology, immunotherapy : CII 1994;39(6):416-9.
-
1994: Hellstrand K; Asea A; Dahlgren C; Hermodsson S
Histaminergic regulation of NK cells. Role of monocyte-derived reactive oxygen metabolites.
Journal of immunology (Baltimore, Md. : 1950) 1994;153(11):4940-7.
-
1994: Hellstrand K; Asea A; Hermodsson S
Histaminergic regulation of antibody-dependent cellular cytotoxicity of granulocytes, monocytes, and natural killer cells.
Journal of leukocyte biology 1994;55(3):392-7.
-
1993: Hellstrand K; Czerkinsky C; Ricksten A; Jansson B; Asea A; Kylefjord H; Hermodsson S
Role of serotonin in the regulation of interferon-gamma production by human natural killer cells.
Journal of interferon research 1993;13(1):33-8.
-
1993: Hellstrand K; Hermodsson S
Serotonergic 5-HT1A receptors regulate a cell contact-mediated interaction between natural killer cells and monocytes.
Scandinavian journal of immunology 1993;37(1):7-18.
-
1993: Olofsson S; Sjöblom I; Hellstrand K; Shugar D; Clairmont C; Hirschberg C
5-Propyl-2-deoxyuridine induced interference with glycosylation in herpes simplex virus infected cells. Nature of PdU-induced modifications of N-linked glycans.
Archives of virology 1993;128(3-4):241-56.
-
1992: Hellstrand K; Kylefjord H; Asea A; Hermodsson S
Regulation of the natural killer cell response to interferon-alpha by biogenic amines.
Journal of interferon research 1992;12(3):199-206.
-
1991: Hellstrand K; Hermodsson S
Cell-to-cell mediated inhibition of natural killer cell proliferation by monocytes and its regulation by histamine H2-receptors.
Scandinavian journal of immunology 1991;34(6):741-52.
-
1991: Hellstrand K; Kjellson B; Hermodsson S
Monocyte-induced down-modulation of CD16 and CD56 antigens on human natural killer cells and its regulation by histamine H2-receptors.
Cellular immunology 1991;138(1):44-54.
-
1990: Hellstrand K; Asea A; Hermodsson S
Role of histamine in natural killer cell-mediated resistance against tumor cells.
Journal of immunology (Baltimore, Md. : 1950) 1990;145(12):4365-70.
-
1990: Hellstrand K; Hermodsson S
Monocyte-mediated suppression of IL-2-induced NK-cell activation. Regulation by 5-HT1A-type serotonin receptors.
Scandinavian journal of immunology 1990;32(2):183-92.
-
1990: Hellstrand K; Hermodsson S
A cell-to-cell mediated interaction involving monocytes and non-T/CD16+ natural killer (NK) cells is required for histamine H2-receptor-mediated NK-cell activation.
Scandinavian journal of immunology 1990;31(5):631-44.
-
1990: Hellstrand K; Hermodsson S
Enhancement of human natural killer cell cytotoxicity by serotonin: role of non-T/CD16+ NK cells, accessory monocytes, and 5-HT1A receptors.
Cellular immunology 1990;127(1):199-214.
-
1990: Hellstrand K; Hermodsson S
Synergistic activation of human natural killer cell cytotoxicity by histamine and interleukin-2.
International archives of allergy and applied immunology 1990;92(4):379-89.
-
1989: Hellstrand K; Hermodsson S
Interleukin-2 can induce suppression of human natural killer cell cytotoxicity.
Clinical and experimental immunology 1989;77(3):410-6.
-
1989: Hellstrand K; Hermodsson S
An immunopharmacological analysis of adrenaline-induced suppression of human natural killer cell cytotoxicity.
International archives of allergy and applied immunology 1989;89(4):334-41.
-
1987: Hellstrand K; Hermodsson S
Role of serotonin in the regulation of human natural killer cell cytotoxicity.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(3):869-75.
-
1987: Hellstrand K; Hermodsson S
Differential effects of histamine receptor antagonists on human natural killer cell activity.
International archives of allergy and applied immunology 1987;84(3):247-55.
-
1987: Strannegård O; Björkander J; Hellstrand K; Pacsa A; Hermodsson S; Hanson L A
Interferon and beta 2-microglobulin in patients with common variable immunodeficiency or selective IgA deficiency.
International archives of allergy and applied immunology 1987;84(3):217-22.
-
1986: Bergström T; Biberfeldt G; Böttiger B; Håkansson C; Hellstrand K; Hermodsson S; Norkrans G; Strannegård O; Thorén K
Impaired production of alpha and gamma interferon in asymptomatic homosexual males.
European journal of clinical microbiology 1986;5(5):523-9.
-
1986: Hellstrand K; Hermodsson S
Histamine H2-receptor-mediated regulation of human natural killer cell activity.
Journal of immunology (Baltimore, Md. : 1950) 1986;137(2):656-60.
-
1985: Hellstrand K; Hermodsson S; Strannegård O
Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(6):4095-9.
Sign-in to see more
